^
+ Follow YERVOY Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1210031
                    [Title] => Bristol-Myers skin cancer drug Yervoy misses goal in study of additional, prostate cancer use
                    [Summary] => 

Bristol-Myers Squibb Co.'s skin cancer treatment Yervoy missed a main goal of achieving a significant improvement in overall survival compared to a fake drug when tested in patients with an advanced form of prostate cancer, the drugmaker said Thursday.

[DatePublished] => 2013-09-14 06:11:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://img842.imageshack.us/img842/7071/3hew.jpg ) [1] => Array ( [ArticleID] => 706062 [Title] => European regulators OK Bristol-Myers cancer drug [Summary] =>

Drugmaker Bristol-Myers Squibb Co. said Thursday the European Commission has approved its treatment Yervoy for use in adults with previously treated advanced melanoma, the deadliest type of skin cancer.

[DatePublished] => 2011-07-15 01:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) ) )
YERVOY
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1210031
                    [Title] => Bristol-Myers skin cancer drug Yervoy misses goal in study of additional, prostate cancer use
                    [Summary] => 

Bristol-Myers Squibb Co.'s skin cancer treatment Yervoy missed a main goal of achieving a significant improvement in overall survival compared to a fake drug when tested in patients with an advanced form of prostate cancer, the drugmaker said Thursday.

[DatePublished] => 2013-09-14 06:11:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://img842.imageshack.us/img842/7071/3hew.jpg ) [1] => Array ( [ArticleID] => 706062 [Title] => European regulators OK Bristol-Myers cancer drug [Summary] =>

Drugmaker Bristol-Myers Squibb Co. said Thursday the European Commission has approved its treatment Yervoy for use in adults with previously treated advanced melanoma, the deadliest type of skin cancer.

[DatePublished] => 2011-07-15 01:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with